1-20 of 38
Keywords: Cognition
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Eur Neurol (2024) 87 (4): 147–158.
Published Online: 29 July 2024
...Lulu Yao; Jingnian Ni; Mingqing Wei; Ting Li; Ziyi Long; Jing Shi; Jinzhou Tian Introduction: Depression has been associated with cognitive performance, but whether sociodemographic and clinical characteristics might influence this association is not well elaborated. This study aimed to further...
Journal Articles
Eur Neurol (2021) 84 (6): 472–480.
Published Online: 02 August 2021
...Yulin Luo; Li Tan; Joseph Therriault; Hua Zhang; Ying Gao; and the Alzheimer’s Disease Neuroimaging Initiative Background: Apolipoprotein E ( APOE ) ε4 is highly associated with mild cognitive impairment (MCI). However, the specific influence of APOE ε4 status on tau pathology and cognitive decline...
Journal Articles
Eur Neurol (2021) 84 (4): 280–287.
Published Online: 02 June 2021
...Ji Won Han; Hyunna Lee; Subin Lee; Haejin Kim; Grace Eun Kim; Jong Bin Bae; Seung Wan Suh; Jae Hyoung Kim; Ki Woong Kim Introduction: The irregular shapes of white matter hyperintensities (WMHs) are associated with poor cognitive function, diabetes, or lacunes. However, the association between...
Journal Articles
Eur Neurol (2021) 84 (4): 254–264.
Published Online: 11 May 2021
...Ping Qu; Jin-Xia Yu; Gui-Hai Chen Background: Fibromyalgia (FM) is a chronic widespread pain disorder associated with fatigue, tender points, sleep disturbances, and mood disorders. Symptoms associated with FM also include decreased cognitive function in which the neural basis is poorly understood...
Journal Articles
Eur Neurol (2021) 84 (3): 175–182.
Published Online: 08 April 2021
...Ozge Arici Duz; Ozlem Saatci; Ece Zeynep Karakulak; Erkingul Birday; Lutfu Hanoglu Background: Multiple Sclerosis (MS) is a neuroinflammatory, neurodegenerative, demyelinating disease that causes cognitive, olfactory, and other neurological dysfunctions. Radiologically Isolated Syndrome (RIS...
Journal Articles
Eur Neurol (2020) 83 (4): 426–432.
Published Online: 05 August 2020
...Sjors C.F. van de Weijer; Annelien A. Duits; Bastiaan R. Bloem; Nienke M. de Vries; Roy P.C. Kessels; Sebastian Köhler; Gerrit Tissingh; Mark L. Kuijf Cognitive training (CT) shows modest positive effects on cognitive function in patients with Parkinson’s disease (PD). Gamification may enhance...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Eur Neurol (2014) 72 (Suppl. 1): 9–11.
Published Online: 26 September 2014
.... THC:CBD oromucosal spray was well tolerated in these studies, with no evidence of effects typically associated with recreational cannabis use. In a subsequent post approval clinical trial, THC:CBD oromucosal spray had no statistically significant effect on cognition and mood compared with placebo...
Journal Articles
Eur Neurol (2014) 71 (5-6): 262–270.
Published Online: 12 February 2014
...Li Feng; Ding Bang Chen; Le Hou; Lin Huan Huang; Shu Yang Lu; Xiu Ling Liang; Xun Hua Li Background: Previous studies have shown cognitive impairment in patients with spinocerebellar ataxia type 3 (SCA3). However, there is a lack of data on Chinese patients with SCA3. Method: We investigated 22...
Journal Articles
Eur Neurol (2014) 71 (Suppl. 1): 4–9.
Published Online: 22 January 2014
... available in 2013 and are reviewed. A randomized, placebo controlled long-term follow-up clinical trial with THC:CBD spray versus placebo demonstrated that it was not associated with cognitive decline, depression or significant mood changes after 12 months of treatment. Furthermore, in a prospective...
Journal Articles
Eur Neurol (2014) 71 (3-4): 208–212.
Published Online: 21 January 2014
...Ayhan Koksal; Cahit Keskinkılıc; Mehmet Vedat Sozmen; Ayten Ceyhan Dirican; Fikret Aysal; Yavuz Altunkaynak; Sevim Baybas Aim: In this study, cognitive functions of 9 patients developing parkinsonism due to chronic manganese intoxication by intravenous methcathinone solution were investigated using...
Journal Articles
Eur Neurol (2012) 68 (6): 361–366.
Published Online: 23 October 2012
...Carmen Sáez-Zea; Francisco Escamilla-Sevilla; Majed J. Katati; Adolfo Mínguez-Castellanos Background: Subthalamic nucleus deep brain stimulation (STN-DBS) improves motor function in selected patients with Parkinson’s disease (PD) but can be associated with variable changes in cognitive functions...
Journal Articles
Eur Neurol (2012) 67 (6): 377–384.
Published Online: 17 May 2012
... and Cognitive Functions [FSMC], Fatigue Severity Scale, and Modified Fatigue Impact Scale), depression (Beck Depression Inventory Fast Screen), cognition (Brief Repeatable Battery of Neuropsychological Tests) and upper and lower extremity functions (Nine-Hole Peg Test and 25-foot walk). Results: Depending...
Journal Articles
Eur Neurol (2012) 67 (3): 162–166.
Published Online: 20 January 2012
...C. Lang; C. Reiss; M. Mäurer Immunomodulating therapies may prevent relapses in multiple sclerosis and stabilize neurological status. However, little is known about the influence particularly of newer drugs on cognitive functions. We conducted an open-label prospective study to demonstrate whether...
Journal Articles
Eur Neurol (2011) 66 (6): 351–358.
Published Online: 25 November 2011
... the impact of SILs on cognitive functioning following CAS. Methods: The retrospective study separated 131 patients with unilateral carotid stenosis into three groups: medication only, MRI-evaluated CAS and CT-evaluated CAS, and compared the sociodemographic factors, post-CAS images and Mini-Mental State...